- Home
- VEEE vs NEUP Comparison
VEEE vs NEUP Comparison
Compare VEEE & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- NEUP
- Stock Information
- Founded
- VEEE 1994
- NEUP 1996
- Country
- VEEE United States
- NEUP United States
- Employees
- VEEE N/A
- NEUP N/A
- Industry
- VEEE Marine Transportation
- NEUP
- Sector
- VEEE Industrials
- NEUP
- Exchange
- VEEE Nasdaq
- NEUP Nasdaq
- Market Cap
- VEEE 6.1M
- NEUP 17.4B
- IPO Year
- VEEE 2021
- NEUP N/A
- Fundamental
- Price
- VEEE $0.41
- NEUP $5.09
- Analyst Decision
- VEEE
- NEUP Strong Buy
- Analyst Count
- VEEE 0
- NEUP 1
- Target Price
- VEEE N/A
- NEUP $21.00
- AVG Volume (30 Days)
- VEEE 1.1M
- NEUP 1.4M
- Earning Date
- VEEE 03-25-2025
- NEUP 02-13-2025
- Dividend Yield
- VEEE N/A
- NEUP N/A
- EPS Growth
- VEEE N/A
- NEUP N/A
- EPS
- VEEE N/A
- NEUP N/A
- Revenue
- VEEE $20,949,492.00
- NEUP N/A
- Revenue This Year
- VEEE $76.99
- NEUP N/A
- Revenue Next Year
- VEEE N/A
- NEUP N/A
- P/E Ratio
- VEEE N/A
- NEUP N/A
- Revenue Growth
- VEEE N/A
- NEUP N/A
- 52 Week Low
- VEEE $0.31
- NEUP $2.12
- 52 Week High
- VEEE $1.37
- NEUP $16.08
- Technical
- Relative Strength Index (RSI)
- VEEE 47.54
- NEUP N/A
- Support Level
- VEEE $0.40
- NEUP N/A
- Resistance Level
- VEEE $0.45
- NEUP N/A
- Average True Range (ATR)
- VEEE 0.06
- NEUP 0.00
- MACD
- VEEE -0.00
- NEUP 0.00
- Stochastic Oscillator
- VEEE 21.80
- NEUP 0.00
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.